Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration

Alhashmi, Hani; AlSagheir, Ahmed; Estanislao, A; Bacal, Jenifer; Alsuhebah, Ashraf; Alblowe, Belal; Raslan, Heba; Alsaber, Arwa; Al-Bahrani, Ahmed Z.; AlMulhem, Norah A.; Alamri, Amal; Alsaleh, Khalid; Albeihany, Amal; Alabdulwahab, Amal; Bakkar, Mohammed; Kaloyannidis, Panayotis

doi:10.1038/s41409-020-0793-9

Cited by 7 publications

(5 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A further more detailed analysis of the methodology of cost analysis can be very useful to agree on better options for cost comparison. The complexity in the definition and practice of cost analysis of hematopoietic stem cell transplantation programs has been reported by Al-Hashmi et al 2020 [ 46 ].…”

Section: Discussionmentioning

confidence: 99%

Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs

et al. 2021

View full text Add to dashboard Cite

The number of Hematopoietic Stem Cell Transplantations has risen in the past 20 years. The practice of outpatient Hematopoietic Stem Cell Transplantation programs is increasing in an attempt to improve the quality of patient care and reduce the demand for hospital admission. A systematic review of 29 comparative studies between in-hospital and outpatient treatment of Hematopoietic Stem Cell Transplantation, with no restriction by outpatient regime was conducted. This study aims to analyse the current evidence on the effects of the outpatient model on patient-centred outcomes, comparing both in-hospital and outpatient models for autologous and allogeneic HSCT using the Triple Aim framework: health outcomes, costs and experience of care. We found evidence on improved health outcomes and quality of life, on enhanced safety and effectiveness and on reduced overall costs and hospital stays, with similar results on overall survival rates comparing both models for autologous and allogeneic patients. We also found that the outpatient Hematopoietic Stem Cell Transplantation is a safe practice as well as less costly, it requires fewer days of hospital stay both for autologous and allogeneic transplantations. Under a situation of an increasing number of transplants, rising healthcare costs and shortages of hospital capacity, incorporating outpatient models could improve the quality of care for people requiring Hematopoietic Stem Cell Transplantation programs.

show abstract

Section: Discussionmentioning

confidence: 99%

Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Recent experience in establishing HSCT centres in Saudi Arabia demonstrates the benefit of collaboration, with reduction in overall cost and project duration. 32 Many of the challenges described that limit the establishment of HSCT services in Tanzania are similar to those faced in other LMIC. Therefore, the strategy for developing an HSCT centre in Tanzania could be used as a model for other countries.…”

Section: Moving Forwardmentioning

confidence: 97%

“…Co‐operation between different centres may enable a more unified approach to securing national and international funding. Recent experience in establishing HSCT centres in Saudi Arabia demonstrates the benefit of collaboration, with reduction in overall cost and project duration 32 …”

Section: Unmet Needs Of Stem Cell Transplantation In Low To Middle Inmentioning

confidence: 99%

Haematopoietic stem cell transplantation in Tanzania

et al. 2020

View full text Add to dashboard Cite

“…These centers provide both autologous and allogeneic stem cell transplantation distributed between MOH and other public non-MOH sectors. New services limited to autologous stem cell transplant in Makkah and Al-Madinah cities are being introduced [20]. A national marrow donor registry is being established to facilitate matched unrelated donor transplant.…”

Section: Stem Cell Transplant and High Dose Chemotherapymentioning

confidence: 99%

General Oncology Care in the Kingdom of Saudi Arabia

Abusanad

Alghamdi

Bakkar

et al. 2022

Cancer in the Arab World

Self Cite

View full text Add to dashboard Cite

The Kingdom of Saudi Arabia is the largest country in the gulf region. With the recognized increasing cancer burden globally and locally, plus a young population with increasing life expectancy, challenges to provide optimal healthcare are substantial. Several landmark achievements made KSA a pioneer in regional cancer care over the past half a century. Advances in different aspects of cancer care have been commenced to match the aspired vision of 2030. This chapter describes past, present milestones and models of oncology care in the Kingdom and highlights future challenges and plans to improve cancer care further.

show abstract

Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration

Cited by 7 publications

References 8 publications

Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs

Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs

Haematopoietic stem cell transplantation in Tanzania

General Oncology Care in the Kingdom of Saudi Arabia

Contact Info

Product

Resources

About